Naproxene Eg

Naproxen, the active ingredient in Naproxene Eg, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is employed to relieve pain, reduce inflammation, and lower fever in adult patients. GNH USA supplies Naproxene Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxene Eg, an NSAID, acts on inflammatory pathways to manage several common conditions.

Pain: Provides analgesia for mild to moderate acute pain such as dental or postoperative discomfort. Inflammation: Reduces swelling and stiffness in osteoarthritis and rheumatoid arthritis. Fever: Lowers elevated body temperature associated with viral or bacterial infections. Musculoskeletal disorders: Alleviates pain and inflammation in back strain, tendonitis and other soft‑tissue injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset, including dyspepsia or heartburn. - Nausea or vomiting. - Headache. - Dizziness. - Mild skin rash. - Elevated liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal impairment or failure. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatotoxicity. - Anaphylactic or anaphylactoid reactions.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

Assess gastrointestinal risk: avoid in patients with active ulcer disease or a history of GI bleeding. Evaluate cardiovascular risk: use the lowest effective dose in patients with heart disease. Monitor renal function: caution in those with chronic kidney disease or dehydration. Use lowest effective dose: limit duration to the shortest period necessary for symptom control. Avoid in known hypersensitivity to naproxen or other NSAIDs. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Naproxen can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - Lithium: naproxen may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: increased ulcer risk. - Methotrexate: reduced clearance leading to toxicity. - Antihypertensive agents (e.g., ACE inhibitors, diuretics): possible reduction in antihypertensive effect. - Alcohol: potentiates gastric irritation and bleeding.